long term use of glp 1 agonists Potential GLP-1 and GIP/GLP-1 Receptor for Respiratory Disorders: Where Are We at? Benefits and Risks of GLP-1

The Short Half-Life of Glucagon-like Peptide-1 in Plasma Does Not Reflect Its Long-Lasting Beneficial Effects

The new GLP-1 receptor agonists can cost around $1,000 per month without insurance, and coverage can vary by source of insurance

Hypoglycaemia is only a potential issue if GLP-1 analogues are combined with a sulfonylurea or insulin

Controversy exists on whether GLP-1Rs exist on pancreatic cells, with evidence pointing to an indirect effect of GLP-1RAs on glucagon inhibition

obesity and diabetes

Results of these trials showed GLP-1 agonists have a favorable safety profile, with most side effects being mild and temporary